BMS-986209
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 04, 2022
A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants
(clinicaltrials.gov)
- P1; N=114; Completed; Sponsor: Bristol-Myers Squibb; Not yet recruiting ➔ Completed; Trial completion date: Aug 2020 ➔ Aug 2021; Trial primary completion date: Jul 2020 ➔ Aug 2021
Clinical • Trial completion • Trial completion date • Trial primary completion date
November 15, 2019
A First-in-Human Study to Assess Single and Multiple Doses of BMS-986209 in Healthy Participants
(clinicaltrials.gov)
- P1; N=88; Not yet recruiting; Sponsor: Bristol-Myers Squibb
Clinical • New P1 trial
1 to 2
Of
2
Go to page
1